NCT03384186View on ClinicalTrials.gov

A Study of Modified Release Formulations of Danicopan in Healthy Adult Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

December 1, 2017

Primary Completion Date

March 21, 2018

Study Completion Date

March 21, 2018

Conditions
Healthy
Interventions
DRUG

Danicopan Modified Release Prototype 1

Danicopan (400 milligrams \[mg\]) oral tablet.

DRUG

Danicopan Modified Release Prototype 2

Danicopan (400 mg) oral tablet.

DRUG

Danicopan Modified Release Prototype 3

Danicopan (800 mg) oral tablet.

Trial Locations (1)

NG111 6JS

Clinical Trial Site, Ruddington

Sponsors
All Listed Sponsors
collaborator

Achillion, a wholly owned subsidiary of Alexion

INDUSTRY

lead

Alexion Pharmaceuticals, Inc.

INDUSTRY